Exosomes derived from atorvastatin-pretreated MSC accelerate diabetic wound repair by enhancing angiogenesis via AKT/eNOS pathway

BACKGROUND: Mesenchymal stem cell (MSC)-derived exosomes emerge as promising candidates for treating delayed wound healing in diabetes due to the promotion of angiogenesis. Preconditioned MSC with chemical or biological factors could possibly enhance the biological activities of MSC-derived exosomes...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Muyu, Liu, Wei, Li, Junxian, Lu, Junxi, Lu, Huijuan, Jia, Weiping, Liu, Fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7425015/
https://www.ncbi.nlm.nih.gov/pubmed/32787917
http://dx.doi.org/10.1186/s13287-020-01824-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7425015/
https://www.ncbi.nlm.nih.gov/pubmed/32787917
http://dx.doi.org/10.1186/s13287-020-01824-2

Ejemplares similares